Market Trends of Bioreactor Industry
The Single-use Bioreactors Segment is Expected to Have A High Growth Rate During the Forecast Period
- Single-use bioreactors (SUB) from the material type segmentation are expected to have a high growth rate during the forecast period of the study. Recently, single-use bioreactors have been increasingly adopted in modern biopharmaceutical processes. This is primarily due to their unique ability to enhance flexibility, reduce investment, and limit operational costs.
- Owing to the high adoption rate and the increasing preference for deploying SUBs, the market players are continuously focusing on product launches and innovations. For instance, in February 2021, WuXi Biologics's MFG5 Drug Substance (DS) manufacturing facility in China successfully launched a GMP operation with a capacity of 36,000L, deploying nine 4,000L single-use bioreactors. As a major landmark in the company's global capacity planning, the GMP launch of MFG5 brings WuXi Biologics' current capacity to 90,000L, greatly enhancing the capability to enable global partners.
- Also, in June 2022, ABEC announced that mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an additional ABEC 4,000L single-use custom single-run (CSR) bioreactor. Therefore, due to the above-mentioned factors, the segment is expected to witness growth.
Understand The Key Trends Shaping This Market
Download PDF
North America Holds a Significant Market Share Currently, which is Expected to Continue Over the Forecast Period
- North America currently holds a significant share of the market for bioreactors, and it is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the rise in collaboration among the industry and academic institutions. The United States holds the majority of the market in the North American region because pharmaceuticals and hi-tech product makers have announced multimillion-dollar investments to expand manufacturing capabilities.
- Additionally, the United States and Canada, two of the largest countries in this region, spend a lot on research and development expenses. For instance, according to the data published by NIH in May 2022, the United States spent around USD 7,847 million in biotechnology research in 2021, and it is expected to reach USD 8,142 million in 2022. The high amount being spent is expected to boost market growth since it translates to greater demand for new drugs and pharmaceutical ingredients that are manufactured by bioreactors.
- Various strategies, such as research and development, mergers and acquisitions, and product launches, are being adopted by domestic companies to strengthen their market position. For instance, in March 2021, Thermo Fisher Scientific launched its HyPerforma DynaDrive 3,000 L and HyPerforma DynaDrive 5,000 L single-use bioreactors due to strong demand for large-scale single-use systems. Product launches, such as these, are expected to boost the market growth during the forecast period.
- Also, the growing demand for biopharmaceutical products in the region and the focus on increasing localized production are expected to have a positive impact on the market over the forecast period.
Get Analysis on Important Geographic Markets
Download PDF
